KIF2B and glioblastoma: To confirm our current in vitro and xenograft data, we immunostained DHC2 and KIF2B proteins in 9 cases of GBM tissue samples from patients with recurrent GBM who were treated with TMZ before their second surgery, and in 12 samples of primary GBMs without TMZ treatment.